Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01).
Saved in:
| Title: | Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01). |
|---|---|
| Authors: | Vergnenègre A; Centre Hospitalier Universitaire (CHU) Dupuytren, Limoges, France., Basse V; CHU Morvan, Brest, France., Le Garff G; CH Yves-Le-Foll, Saint-Brieuc, France., Bylicki O; Hôpital d'Instruction des Armées Percy, Clamart, France., Dubos-Arvis C; Centre François-Baclesse, Caen, France., Comet B; Centre Catalan d'Oncologie, Perpignan, France., Marcq M; CH Départemental Vendée, Les Oudairies, La Roche-Sur-Yon, France., Le Treut J; CH du Pays d'Aix, Aix-En-Provence, France., Auliac JB; Hôpital Quesnay, Mantes-La-Jolie, France., Madroszyk A; Institut Paoli-Calmettes, Marseille, France., Fraboulet G; CH René-Dubos, Cergy-Pontoise, France., Crequit J; CH Laennec, Creil, France., Thomas P; CH Intercommunal (CHI) Des Alpes-Du-Sud, Gap, France., Paleiron N; Hôpital d'Instruction Des Armées Sainte-Anne, Toulon, France., Monnet I; CHI Créteil, Créteil, France. |
| Corporate Authors: | French Lung Cancer Group |
| Source: | Cancer management and research [Cancer Manag Res] 2019 Dec 27; Vol. 11, pp. 10821-10826. Date of Electronic Publication: 2019 Dec 27 (Print Publication: 2019). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101512700 Publication Model: eCollection Cited Medium: Print ISSN: 1179-1322 (Print) Linking ISSN: 11791322 NLM ISO Abbreviation: Cancer Manag Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-1322 |
|---|---|
| DOI: | 10.2147/CMAR.S219984 |
